End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma

Table 2 Univariable and multivariable analyses to identify predictors of post-hepatectomy liver failure

Variable	Univariate analysis		Multivariate analysis
	Odds ratio	P value	Odds ratio	P value
Age, years	1.60 (0.58-4.40)	0.360	3.02 (0.77-11.78)	0.112
Male sex	0.61 (0.19-1.96)	0.411	0.68 (0.15-3.07)	0.616
Platelet count, ×109/L	2.97 (1.14-7.73)	0.026	5.17 (1.31-20.35)	0.019
Blood loss, mL	2.27 (0.87-5.92)	0.092	1.14 (0.33-3.91)	0.839
Tumor number (≥ 3)	0.58 (0.13-2.62)	0.479	0.31 (0.05-2.14)	0.235
Albumin, g/L	3.67 (1.29-10.46)	0.015	3.90 (1.14-13.35)	0.030
Prothrombin time, s	1.45 (0.57-3.68)	0.439	1.39 (0.40-4.82)	0.605
sFLR	10.08 (3.49-29.10)	< 0.001	29.92 (6.51-137.46)	< 0.001
MELD	5.98 (2.31-15.45)	< 0.001	7.89 (2.23-28.01)	0.001

sFLR: Standardized future liver remnant; MELD: Model for end-stage liver disease.